Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Withdrawn 1Terminated 1

Sponsor Class

UNKNOWN 2OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Advanced Cancer 1

Interventions

Capecitabine 3nabiximols 2icaritin 2pembrolizumab 1S 1 (combination) 1Radiotherapy, Image-Guided 1Radiotherapy 1Oxaliplatin 1Drug Therapy 1Chlorogenic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × UNKNOWN × nabiximols × Clear all
NCT01975688 2016-08-11

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

GWPharm

Phase 1 Terminated
10 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02432612 2016-03-02

A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer

GWPharm

Phase 1 Withdrawn

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡